Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
1,1 miljoen euro subsidie voor snelle diagnose beroertes
feb 2019 | Neuro-vasculair